Klinefelter Syndrome
En Español (Spanish Version)

Klinefelter syndrome (KS) occurs in some men who have more than one X chromosome (XXY).

Klinefelter's Syndrome

Copyright © Nucleus Medical Media, Inc.

Males usually inherit a single X chromosome from their mother and a single Y chromosome from their father. Males with KS get at least one extra X chromosome.

Risk Factors
A risk factor is something that increases your chance of KS. Women over age 35 may have a slightly increased chance of having a child with KS. There are no other known risk factors for this disorder.

XXY occurs in approximately 1 out of 580 live male births, but many men with it do not develop KS. When KS does develop, it usually goes undetected until puberty or sometimes much later.

Characteristics may include:

  • For babies: Smaller birth weight and slower muscle and motor development
  • For children and adults:
    • Small firm testes, small penis
    • Abnormal body proportions (long legs, short trunk)
    • Tallness with extra long arms and legs
    • Social and learning disabilities (common)
    • Personality impairment
    • Attention deficit hyperactivity disorder (ADHD)
    • Speech and language problems—Children with KS often learn to speak later than other children do. They may have a difficult time reading and writing.
    • Normal to borderline IQ
    • Lack of ability to produce sperm (common)
    • Lack of facial and body hair
    • Enlarged breasts (common)
    • Diminished sex drive, sexual dysfunction
Men with KS have an increased risk of:

A test called a karyotype is used to diagnose KS. In the case of KS, there are usually 47 chromosomes rather than the normal 46.

Many men with XXY do not know they have the condition. The diagnosis may be found:

  • When amniocentesis is done
  • In babies— with undescended testes or very small penis
  • In children—when the child is having problems learning
  • In adolescents—when the child has delayed puberty or excessive breast development
  • In adults—when the man has fertility concerns
Treatment of KS includes:

The main treatment is testosterone . When boys with KS are 10-12 years old, their hormone levels are checked yearly. If testosterone levels are low, then treatment may be helpful. Men diagnosed may also benefit from taking the hormone. However, testosterone cannot reverse infertility.

The benefits of testosterone include:

  • Increased strength
  • More muscular, male appearance
  • Growth of facial and body hair
  • Better self-esteem
  • Modulation of mood
  • Increased energy
  • Increased ability to concentrate
  • Greater sex drive
  • Improved bone density
Speech and Language Therapy
This therapy should begin in early childhood to avoid social and school learning problems. Treatment may involve:

  • Speech therapy
  • Special education services
  • Extra support and help with learning from parents and teachers
  • Social skills training and psychological counseling
Currently, there are no known ways of preventing KS.

Klinefelter Syndrome and Associates

National Institute of Child Health & Human Development

Canadian Psychiatric Association

Canadian Psychological Association

Klinefelter syndrome. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated February 28, 2013. Accessed October 11, 2011.

Tell me about 47, XXY. Klinefelter Syndrome and Associates website. Available at: http://www.genetic.org/knowledge/support/action/199/#Brief%20Introduction%20to%20Klinefelter%20syndrome. Accessed August 20, 2013.

Klinefelter syndrome: overview. National Institute of Child Health & Human Development website. Available at: http://www.nichd.nih.gov/publications/pubs/klinefelter.cfm. Updated April 3, 2013. Accessed August 20, 2013.

Last Reviewed August 2013

Health Information Library content is provided by EBSCO Publishing, fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.


This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.


To send comments or feedback to EBSCO's Editorial Team regarding the content please e-mail healthlibrarysupport@ebscohost.com.